AGIO Agios Pharmaceuticals, Inc. - Common Stock
NASDAQ · Biotechnology · SEC EDGAR पर देखें ↗ बंद अक्ट 2, 2026 10-K/10-Q जुल 30, 2026
$31.80
· 52 सप्ताह की सीमा का %
· निम्न से ऊपर
· उच्च तक
$22.2452w निम्न
$46.0052w उच्च
मार्केट कैप (MRQ)
$1.90B
P/E (TTM)
-4.5
EPS (TTM)
$-7.02
राजस्व (TTM)
$98M
आपके बैज
52W रेंज
$22–$46
विश्लेषक रेटिंग
BUY
मूल्य लक्ष्य
$46
P/E
-4.5
ROE
-34.3%
शुद्ध लाभ मार्जिन
-418.2%
आपकी बैज स्ट्रिप खाली है — इस पेज पर कहीं भी एक मीट्रिक पिन करें।
AGIO स्टॉक स्नैपशॉट मूल्य, बाजार पूंजीकरण, P/E, EPS, ROE, ऋण/इक्विटी, 52-सप्ताह की सीमा
मूल्य
$31.80
मार्केट कैप (MRQ)
$1.90B
P/E (TTM)
-4.5
EPS (TTM)
$-7.02
राजस्व (TTM)
$98M
ROE (TTM)
-34.3%
52W रेंज
$22–$46
AGIO स्टॉक मूल्य चार्ट तकनीकी संकेतकों के साथ दैनिक OHLCV — पैन, ज़ूम और अपना दृश्य कस्टमाइज़ करें
सीमा
बार
बार ग्रैन्युलैरिटी चयनित अवधि के अनुसार अनुकूलित होती है — बार के लिए ओपन/हाई/लो/क्लोज देखने के लिए चार्ट पर होवर करें।
Agios Pharmaceuticals, Inc. - Common Stock के बारे में विकिपीडिया से कंपनी का अवलोकन
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 (or 2007) by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013.
History
In 2012, Agios was named among the defendants in a lawsuit against one of its founders, Craig Thompson, alleging that Thompson used research illegally taken from the Abramson Family Cancer Research Institute in research at Agios.
In May 2016, the company announced it would launch partnership with Celgene, developing metabolic immuno-oncology therapies and licensing AG-221 as well as AG-881 to Celgene, potentially garnering Agios $120 million in drug licensing payments.
In April 2017, the company raised $250 million in a new stock offering in anticipation of approval for its first cancer drug, enasidenib, by the US Food and Drug Administration.
In December 2017, the company filed a New Drug Application with the US FDA for ivosidenib for the treatment of adult patients with relapsed or refractory acute myeloid leukemia with an IDH1 mutation.
In November 2019, Agios announced an underwritten public offering of 8,250,000 shares of common stock at a price of $31.00 per share which would result in approximately $256 million aggregate gross proceeds.
In April 2022, the FDA approved mitapivat as first disease-modifying therapy for hemolytic anemia in adults with pyruvate kinase deficiency.
Corporate governance
As of August 2022, Agios' CEO is Brian Goff.
Agios was established as a private company and converted to a public company with its initial public offering in July 2013 and subsequent listing on NASDAQ.
== References ==
स्रोत: विकिपीडिया (अंग्रेज़ी), CC BY-SA 4.0 · विकिपीडिया पर देखें ↗
क्षेत्रHealthcare
उद्योगBiotechnology
कर्मचारी539
देशUS
10-वर्षीय प्रदर्शन राजस्व, शुद्ध आय, मार्जिन और ईपीएस रुझान
राजस्व$54M2016-12-31 → 2025-12-31
EPS$-7.122019-12-31 → 2025-12-31
फ्री कैश फ्लो$-377M2016-12-31 → 2025-12-31
शुद्ध मार्जिन-418.2%2017-12-31 → 2025-12-31
मूल्यांकन और अनुपात
मूल्यांकन P/E, P/S, P/B, EV/EBITDA अनुपात — क्या स्टॉक महंगा है या सस्ता?
| मेट्रिक | 5Y रुझान | AGIO | 5Y औसत | सहकर्मी माध्यिका | निर्णय |
|---|---|---|---|---|---|
| P/E (TTM) | -4.55Y औसत ≈-2.0 | ≈-2.0 | · | · | |
| P/S (TTM) | 19.35Y औसत ≈59.0 | ≈59.0 | 25.9 | उचित मूल्य | |
| P/B (MRQ) | 1.85Y औसत ≈1.4 | ≈1.4 | 6.0 | अल्पमूल्यित | |
| मूल्य / FCF (TTM) | -5.25Y औसत ≈-4.5 | ≈-4.5 | · | · | |
| मूल्य / नकदी प्रवाह (TTM) | -5.35Y औसत ≈-4.5 | ≈-4.5 | · | · | |
| Price / Tangible Book (मूल्य / मूर्त पुस्तक) | 2013.95Y औसत ≈1.4 | ≈1.4 | · | · |
सहकर्मी माध्यिका को प्रति मीट्रिक मानकीकृत आधार पर गणना की जाती है और यह हमेशा इस स्टॉक के लिए दिखाए गए TTM/MRQ आधार से मेल नहीं खा सकती है।
लाभप्रदता सकल, परिचालन और शुद्ध मार्जिन; ROE, ROA, ROIC
| मेट्रिक | 5Y रुझान | AGIO | 5Y औसत | सहकर्मी माध्यिका | निर्णय |
|---|---|---|---|---|---|
| परिचालन मार्जिन (TTM) | -466.8%5Y औसत ≈-1558.0% | ≈-1558.0% | -474.4% | शीर्ष स्तर | |
| EBITDA Margin (EBITDA मार्जिन) | -873.9%5Y औसत ≈-1558.0% | ≈-1558.0% | -474.4% | शीर्ष स्तर | |
| Pretax Margin (प्रीटैक्स मार्जिन) | -765.9%5Y औसत ≈-434.8% | ≈-434.8% | -660.8% | कमजोर | |
| शुद्ध लाभ मार्जिन (TTM) | -418.2%5Y औसत ≈-464.6% | ≈-464.6% | -442.9% | शीर्ष स्तर | |
| ROA (TTM) | -31.9%5Y औसत ≈22.9% | ≈22.9% | -34.8% | शीर्ष स्तर | |
| ROE (TTM) | -34.3%5Y औसत ≈13.4% | ≈13.4% | -76.5% | शीर्ष स्तर | |
| ROIC | -39.5% | · | -134.2% | शीर्ष स्तर |
वित्तीय स्वास्थ्य ऋण, तरलता, शोधन क्षमता — बैलेंस शीट की मजबूती
| मेट्रिक | 5Y रुझान | AGIO | 5Y औसत | सहकर्मी माध्यिका | निर्णय |
|---|---|---|---|---|---|
| वर्तमान अनुपात (MRQ) | 10.25Y औसत ≈13.3 | ≈13.3 | 7.7 | मजबूत तरलता | |
| Quick Ratio (त्वरित अनुपात) | 1.15Y औसत ≈1.8 | ≈1.8 | 4.3 | कम तरलता |
विकास राजस्व, EPS और शुद्ध आय वृद्धि: YoY, 3Y CAGR, 5Y CAGR
| मेट्रिक | 5Y रुझान | AGIO | 5Y औसत | सहकर्मी माध्यिका | निर्णय |
|---|---|---|---|---|---|
| Revenue YoY (राजस्व YoY) | 48.0%5Y औसत ≈57.5% | ≈57.5% | · | · | |
| Revenue CAGR 3Y (राजस्व CAGR 3Y) | 56.0% | · | · | · | |
| EPS CAGR 3Y | -24.0% | · | · | · | |
| Net Income CAGR 3Y (शुद्ध आय CAGR 3Y) | -25.1% | · | · | · |
पूंजी दक्षता एसेट टर्नओवर, इन्वेंटरी टर्नओवर, प्राप्य टर्नओवर
| मेट्रिक | 5Y रुझान | AGIO | 5Y औसत | सहकर्मी माध्यिका | निर्णय |
|---|---|---|---|---|---|
| Asset Turnover (परिसंपत्ति टर्नओवर) | 0.05Y औसत ≈0.0 | ≈0.0 | 0.3 | कमजोर | |
| Inventory Turnover (इन्वेंटरी टर्नओवर) | 0.25Y औसत ≈0.2 | ≈0.2 | · | · | |
| Revenue / Employee (राजस्व / कर्मचारी (रिपोर्ट की गई हेडकाउंट, यफाइनांस)। व्युत्पन्न — संग्रहीत SEC-XBRL अवधारणा नहीं है।) | ≈$100.2K | · | · | · |
मान · ≈ 5Y औसत · उद्योग माध्य · माध्य के सापेक्ष निर्णय
Earnings History EPS वास्तविक बनाम अनुमान, आश्चर्य %, बीट दर, अगली आय तिथि
औसत आश्चर्य
5.5%
अगली रिपोर्ट
अक्ट 28, 2026
| Period | रिपोर्ट | EPS Actual | EPS अनुमान | आश्चर्य |
|---|---|---|---|---|
| 30 जून 2026 | जुल 29, 2026 | $-1.69 | $-1.70 | 0.66% |
| 31 मार्च 2026 | $-1.69 | $-1.84 | 8.0% | |
| 31 दिसमबर 2025 | $-1.86 | $-1.99 | 6.3% | |
| 30 सितमबर 2025 | $-1.78 | $-1.94 | 8.1% | |
| 30 जून 2025 | $-1.93 | $-1.84 | -4.7% | |
| 31 मार्च 2025 | $-1.55 | $-1.82 | 14.8% |
पूर्ण मौलिक सभी मेट्रिक्स प्रति वर्ष — आय विवरण, बैलेंस शीट, नकदी प्रवाह
आय विवरण
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $54M | $36M | $27M | $14M | $0 | $0 | $118M | $94M | $43M | $70M | $59M | $65M | |
| Cost of Revenue | $6M | $4M | $3M | $2M | $0 | $0 | $1M | $1M | $0 | $0 | · | · | |
| R&D Expense | $340M | $301M | $296M | $280M | $257M | $221M | $214M | $341M | $293M | $220M | $142M | $100M | |
| SG&A Expense | $180M | $157M | $120M | $122M | $121M | $115M | $102M | $114M | $71M | $51M | $36M | $19M | |
| Operating Expenses | $526M | $462M | $418M | $403M | $378M | $336M | $316M | $457M | $364M | $271M | $178M | $119M | |
| Operating Income | $-472M | $-426M | $-391M | $-389M | $-378M | $-336M | $-316M | $-362M | $-321M | $-201M | $-119M | $-54M | |
| Interest Income | · | · | · | $13M | $836.0K | $7M | $15M | $16M | $6M | $3M | $968.0K | $203.0K | |
| Other Non-op | $2M | $6M | $6M | $7M | $14M | $0 | $0 | · | · | · | · | · | |
| Pretax Income | $-414M | $718M | $-352M | $-232M | $-357M | $-329M | $-301M | $-346M | $-315M | $-198M | $-118M | $-54M | |
| Income Tax | $-1M | $44M | $0 | $0 | · | · | $0 | $0 | $0 | $0 | $0 | $-426.0K | |
| Net Income | $-413M | $674M | $-352M | $-232M | $1.60B | $-327M | $-411M | $-346M | $-315M | $-198M | $-118M | $-54M | |
| EPS (Basic) | $-7.12 | $11.86 | $-6.33 | $-4.23 | $26.55 | $-4.74 | $-6.86 | · | · | · | · | · | |
| EPS (Diluted) | $-7.12 | $11.64 | $-6.33 | $-4.23 | $26.55 | $-4.74 | $-6.86 | · | · | · | · | · | |
| Shares (Basic) | 57,972,004 | 56,807,415 | 55,651,487 | 54,789,435 | 60,447,346 | 68,997,879 | 59,994,539 | · | · | · | · | · | |
| Shares (Diluted) | 57,972,004 | 57,889,255 | 55,651,487 | 54,789,435 | 60,447,346 | 68,997,879 | 59,994,539 | · | · | · | · | · | |
| EBITDA | $-472M | $-426M | $-391M | $-389M | $-378M | $-316M | $-418M | $-362M | $-321M | $-201M | $-119M | $-54M |
बैलेंस शीट
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $89M | $76M | $88M | $139M | $203M | $127M | $81M | $71M | $103M | $161M | $72M | $14M | |
| Short-term Investments | · | · | · | · | · | · | · | $515M | $321M | $381M | · | · | |
| Inventory | $33M | $28M | $19M | $8M | $0 | $15M | $7M | $869.0K | $0 | · | · | · | |
| Prepaid Expense | $44M | $40M | $35M | $39M | $40M | $16M | $24M | $17M | $18M | $10M | $9M | $5M | |
| Current Assets | $942M | $966M | $834M | $833M | $1.06B | $637M | $612M | $614M | $445M | $560M | $337M | $360M | |
| PP&E (Net) | $11M | $12M | $15M | $23M | $29M | $31M | $31M | $24M | $24M | $25M | $23M | $6M | |
| PP&E (Gross) | $71M | $68M | $68M | $73M | $74M | $72M | $64M | $50M | $44M | $39M | $31M | $12M | |
| Accum. Depreciation | $60M | $56M | $52M | $50M | $45M | $41M | $32M | $26M | $19M | $13M | $8M | $6M | |
| Other Non-current Assets | $4M | $5M | $4M | $4M | $3M | $0 | $0 | $238.0K | $891.0K | $2M | $611.0K | $590.0K | |
| Total Assets | $1.30B | $1.66B | $937M | $1.24B | $1.44B | $853M | $891M | $858M | $614M | $619M | $420M | $492M | |
| Accounts Payable | $18M | $17M | $10M | $19M | $17M | $18M | $22M | $18M | $23M | $17M | $15M | $11M | |
| Accrued Liabilities | $45M | $47M | $43M | $30M | $32M | $31M | $53M | $42M | $34M | $32M | $16M | $14M | |
| Current Liabilities | $82M | $81M | $68M | $63M | $60M | $94M | $93M | $94M | $95M | $88M | $53M | $61M | |
| Capital Leases | $22M | $40M | $57M | $72M | $86M | $97M | $106M | · | · | · | · | · | |
| Other Non-current Liabilities | $90.0K | $880.0K | $1M | $3M | $0 | · | · | · | · | · | · | · | |
| Total Liabilities | $104M | $122M | $126M | $138M | $146M | $453M | $250M | $171M | $239M | $261M | · | · | |
| Common Stock | · | · | · | · | $71.0K | $69.0K | $68.0K | $58.0K | $49.0K | $42.0K | $38.0K | $37.0K | |
| Retained Earnings | $-562M | $-149M | $-823M | $-471M | $-239M | $-1.84B | $-1.52B | $-1.10B | $-798M | $-483M | $-285M | $-167M | |
| Treasury Stock | $802M | $802M | $802M | $802M | $802M | $0 | · | · | · | · | · | · | |
| Stockholders' Equity | $1.19B | $1.54B | $811M | $1.10B | $1.29B | $400M | $641M | $688M | $376M | $359M | $345M | $424M | |
| Liabilities + Equity | $1.30B | $1.66B | $937M | $1.24B | $1.44B | $853M | $891M | $858M | $614M | $619M | $420M | $492M | |
| Shares Outstanding | 58,448,592 | 73,372,696,000 | 72,161,489 | 71,256,118 | 70,550,631 | 69,293,920 | 68,401,105 | 58,218,653 | 48,826,153 | 42,220,444 | 37,696,502 | 37,100,513 |
नकदी प्रवाह
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | $8M | $7M | $6M | · | · | · | |
| Stock-based Comp | $53M | $43M | $45M | $49M | $54M | $62M | $58M | $73M | $48M | $42M | $32M | $12M | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | |
| Other Non-cash | · | · | · | · | · | · | $-40M | · | · | · | · | · | |
| Operating Cash Flow | $-373M | $-390M | $-296M | $-309M | $-407M | $-291M | $-371M | $-304M | $-285M | $39M | $-77M | $-59M | |
| CapEx | $4M | $2M | $999.0K | $5M | $6M | $14M | $12M | $7M | $5M | $10M | $20M | $2M | |
| Investing Cash Flow | $377M | $363M | $240M | $243M | $1.25B | $76M | $91M | $-274M | $-58M | $-119M | $128M | · | |
| Stock Issued | · | · | · | · | $0 | $0 | $277M | $516M | $270M | $162M | $0 | $334M | |
| Net Stock Activity | · | · | · | · | $0 | $0 | $277M | $516M | $270M | $162M | · | $334M | |
| Financing Cash Flow | $9M | $14M | $5M | $2M | $-766M | $262M | $290M | $546M | $285M | $170M | $6M | · | |
| Net Change in Cash | $13M | $-12M | $-51M | $-64M | $76M | $47M | $10M | $-32M | $-58M | $89M | $58M | $-58M | |
| Taxes Paid | $628.0K | $43M | $2M | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $-377M | $-392M | $-297M | $-314M | $-413M | $-306M | $-383M | $-311M | $-290M | $29M | $-97M | $-62M |
लाभप्रदता
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -873.9% | -1166.5% | -1459.5% | -2732.1% | · | -155.6% | -361.6% | · | -745.8% | · | · | -82.8% | |
| Net Margin | -764.0% | 1845.9% | -1312.6% | -1627.8% | · | -161.1% | -349.0% | · | -731.6% | · | · | -81.9% | |
| Pretax Margin | -765.9% | 1967.2% | -1312.6% | -1627.8% | · | -161.2% | -349.0% | · | -731.6% | · | · | -82.5% | |
| EBITDA Margin | -873.9% | -1166.5% | -1459.5% | -2732.1% | · | -155.6% | -354.7% | · | -745.8% | · | · | -82.8% | |
| ROA | -27.9% | 51.8% | -32.4% | -17.3% | 140.1% | -37.5% | -47.0% | -47.0% | -51.0% | -38.2% | -25.8% | -15.4% | |
| ROE | -32.2% | 42.5% | -41.5% | -21.6% | 119.4% | -74.4% | -75.6% | -47.8% | -85.7% | -56.4% | -30.6% | -19.2% | |
| ROIC | -39.5% | -25.9% | · | · | · | · | -66.6% | -52.7% | -85.4% | · | · | -12.7% |
तरलता और शोधन क्षमता
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 11.5 | 11.9 | 12.3 | 13.3 | 17.8 | 6.7 | 6.6 | 6.6 | 4.7 | 6.3 | 6.4 | 5.9 | |
| Quick Ratio | 1.1 | 0.9 | 1.3 | 2.2 | 3.4 | 1.4 | 0.9 | 6.3 | 4.5 | 1.8 | 1.4 | 0.2 |
दक्षता
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | 0.0 | · | 0.2 | 0.1 | · | 0.1 | · | · | 0.2 | |
| Inventory Turnover | 0.2 | 0.2 | 0.2 | 0.4 | · | 0.3 | 0.3 | 3.2 | · | · | · | · |
प्रति शेयर
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $20.41 | $26.96 | $14.50 | $20.00 | $23.78 | $5.77 | $9.36 | $11.81 | $7.69 | $8.49 | $9.16 | $11.44 | |
| Revenue / Share | $0.93 | $0.63 | $0.48 | $0.26 | · | · | · | · | · | · | · | · | |
| Cash Flow / Share | $-6.43 | $-6.73 | $-5.32 | $-5.65 | $-6.74 | · | · | · | · | · | · | · | |
| Cash / Share | $1.52 | $1.33 | $1.58 | $2.53 | $3.74 | $1.84 | $1.18 | $1.21 | $2.10 | $3.81 | $1.90 | $0.38 | |
| EPS (TTM) | $-7.12 | $11.64 | $-6.33 | $-4.23 | $26.55 | $-4.74 | $-6.86 | · | · | · | · | $-1.59 |
विकास दरें
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 48.0% | 36.1% | 88.4% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 56.0% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | · | -24.0% | · | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | · | -25.1% | · | · | · | · | · | · | · | · | · | · |
मूल्यांकन (TTM)
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $54M | $36M | $27M | $14M | $0 | $0 | $118M | $94M | $43M | $70M | $59M | $65M | |
| Net Income TTM | $-413M | $674M | $-352M | $-232M | $1.60B | $-327M | $-411M | $-346M | $-315M | $-198M | $-118M | $-54M | |
| Market Cap | $1.59B | $1.88B | $1.25B | $1.55B | $1.79B | $3.00B | $3.27B | $2.68B | $2.79B | $1.76B | $2.45B | $4.16B | |
| P/E | -3.8 | 2.8 | -3.5 | -6.6 | 1.2 | -9.1 | -7.0 | · | · | · | · | -70.5 | |
| P/S | 29.4 | 51.5 | 46.4 | 108.5 | · | · | 27.7 | 28.4 | 64.9 | 25.2 | 41.4 | 63.6 | |
| P/B | 1.3 | 1.2 | 1.5 | 1.4 | 1.4 | 7.5 | 5.1 | 3.9 | 7.4 | 4.9 | 7.1 | 9.8 | |
| P / Tangible Book | 1.3 | 1.2 | 1.5 | 1.4 | 1.4 | 7.5 | · | · | · | · | · | · | |
| P / Cash Flow | -4.3 | -4.8 | -4.2 | -5.0 | -4.4 | -10.3 | -8.8 | -8.8 | -9.8 | 45.7 | -31.8 | -70.0 | |
| P / FCF | -4.2 | -4.8 | -4.2 | -4.9 | -4.3 | -9.8 | -8.5 | -8.6 | -9.6 | 61.5 | -25.2 | -67.5 | |
| Earnings Yield | -26.2% | 35.4% | -28.4% | -15.1% | 80.8% | -10.9% | -14.4% | · | · | · | · | -1.4% |
आय विवरण
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $45M | $21M | $20M | $13M | $12M | $9M | $11M | $9M | $9M | $8M | $7M | $7M | $7M | $6M | $4M | $4M | |
| Cost of Revenue | $3M | $1M | $2M | $2M | $2M | $1M | $1M | $783.0K | $1M | $627.0K | $586.0K | $633.0K | $1M | $554.0K | $413.0K | $517.0K | |
| R&D Expense | $101M | $81M | $88M | $87M | $92M | $73M | $83M | $72M | $77M | $69M | $77M | $82M | $69M | $67M | $70M | $65M | |
| SG&A Expense | $52M | $48M | $52M | $41M | $46M | $42M | $52M | $39M | $36M | $31M | $35M | $26M | $30M | $28M | $33M | $29M | |
| Operating Expenses | $155M | $131M | $142M | $130M | $140M | $115M | $136M | $112M | $114M | $100M | $113M | $108M | $100M | $96M | $103M | $95M | |
| Operating Income | $-111M | $-110M | $-122M | $-117M | $-127M | $-107M | $-125M | $-103M | $-106M | $-92M | $-106M | $-101M | $-94M | $-91M | $-99M | $-91M | |
| Other Non-op | $119.0K | $119.0K | $113.0K | $67.0K | $523.0K | $1M | $2M | $2M | $2M | $2M | $2M | $1M | $2M | $2M | $1M | $1M | |
| Pretax Income | · | · | $-109M | $-103M | · | · | $-105M | $1.00B | · | · | $-96M | $-91M | · | · | · | · | |
| Income Tax | · | · | $-1M | $0 | · | · | $-9M | $53M | · | · | $0 | $0 | · | · | $0 | $0 | |
| Net Income | $-101M | $-99M | $-108M | $-103M | $-112M | $-89M | $-97M | $948M | $-96M | $-82M | $-96M | $-91M | $-84M | $-81M | $37M | $-82M | |
| EPS (Basic) | $-1.69 | $-1.69 | $-1.86 | $-1.78 | $-1.93 | $-1.55 | $-1.65 | $16.65 | $-1.69 | $-1.45 | $-1.71 | $-1.64 | $-1.51 | $-1.47 | $0.68 | $-1.49 | |
| EPS (Diluted) | $-1.69 | $-1.69 | $-1.86 | $-1.78 | $-1.93 | $-1.55 | $-1.44 | $16.22 | $-1.69 | $-1.45 | $-1.71 | $-1.64 | $-1.51 | $-1.47 | $0.68 | $-1.49 | |
| Shares (Basic) | 59,488,871 | 58,782,241 | · | 58,139,277 | 57,932,576 | 57,459,195 | · | 56,939,403 | 56,802,546 | 56,383,475 | · | 55,803,663 | 55,604,330 | 55,265,390 | · | 54,844,579 | |
| Shares (Diluted) | 59,488,871 | 58,782,241 | · | 58,139,277 | 57,932,576 | 57,459,195 | · | 58,432,796 | 56,802,546 | 56,383,475 | · | 55,803,663 | 55,604,330 | 55,265,390 | · | 54,844,579 | |
| EBITDA | $-111M | $-110M | · | $-117M | $-127M | $-107M | · | $-103M | $-106M | $-92M | · | $-101M | $-94M | $-91M | · | $-91M |
बैलेंस शीट
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $100M | $114M | $89M | $93M | $81M | $79M | $76M | $254M | $85M | $119M | · | $64M | $85M | $104M | · | $122M | |
| Inventory | $36M | $35M | $33M | $32M | $31M | $30M | $28M | $26M | $24M | $23M | · | $17M | $16M | $11M | · | $5M | |
| Prepaid Expense | $46M | $47M | $44M | $43M | $45M | $42M | $40M | $40M | $35M | $39M | · | $38M | $37M | $39M | · | $46M | |
| Current Assets | $718M | $835M | $942M | $1.03B | $1.02B | $969M | $966M | $1.07B | $632M | $664M | · | $704M | $757M | $792M | · | $785M | |
| PP&E (Net) | $10M | $11M | $11M | $11M | $11M | $11M | $12M | $12M | $13M | $14M | · | $17M | $20M | $21M | · | $25M | |
| PP&E (Gross) | · | · | $71M | · | · | · | $68M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $60M | · | · | · | $56M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $10M | $4M | $4M | $4M | $4M | $5M | $5M | $4M | $4M | $4M | · | $4M | $4M | $4M | · | $4M | |
| Total Assets | $1.11B | $1.18B | $1.30B | $1.39B | $1.47B | $1.56B | $1.66B | $1.79B | $773M | $850M | · | $1.01B | $1.09B | $1.15B | · | $1.18B | |
| Accounts Payable | $16M | $14M | $18M | $20M | $18M | $14M | $17M | $17M | $10M | $11M | · | $13M | $12M | $9M | · | $10M | |
| Accrued Liabilities | $35M | $26M | $45M | $37M | $35M | $21M | $47M | $33M | $37M | $25M | · | $30M | $29M | $22M | · | $30M | |
| Current Liabilities | $70M | $59M | $82M | $75M | $70M | $52M | $81M | $119M | $63M | $52M | · | $58M | $55M | $45M | · | $54M | |
| Capital Leases | $12M | $17M | $22M | $27M | $31M | $36M | $40M | $45M | $49M | $53M | · | $61M | $65M | $68M | · | $75M | |
| Other Non-current Liabilities | $240.0K | $90.0K | $90.0K | $90.0K | $101.0K | $880.0K | $880.0K | $1M | $1M | $1M | · | $1M | $1M | $1M | · | $1M | |
| Total Liabilities | $82M | $76M | $104M | $101M | $102M | $89M | $122M | $165M | $113M | $106M | · | $120M | $121M | $115M | · | $130M | |
| Retained Earnings | $-762M | $-661M | $-562M | $-454M | $-350M | $-238M | $-149M | $-52M | $-1.00B | $-904M | · | $-727M | $-635M | $-552M | · | $-507M | |
| Treasury Stock | $802M | $802M | $802M | $802M | $802M | $802M | $802M | $802M | $802M | $802M | · | $802M | $802M | $802M | · | $802M | |
| Stockholders' Equity | $1.03B | $1.11B | $1.19B | $1.28B | $1.37B | $1.47B | $1.54B | $1.63B | $661M | $744M | $811M | $887M | $964M | $1.04B | $1.10B | $1.05B | |
| Liabilities + Equity | $1.11B | $1.18B | $1.30B | $1.39B | $1.47B | $1.56B | $1.66B | $1.79B | $773M | $850M | · | $1.01B | $1.09B | $1.15B | · | $1.18B | |
| Shares Outstanding | 59,604,830 | 59,341,338 | 58,448,592 | 58,279,876 | 58,038,545 | 57,886,781 | 57,156,285 | 57,021,543 | 56,875,079 | 56,751,511 | 72,161,489 | 55,883,973 | 55,734,775 | 55,541,367 | 71,256,118 | 54,894,031 |
नकदी प्रवाह
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $16M | $16M | $14M | $12M | $15M | $11M | $11M | $11M | $12M | $9M | $14M | $9M | $12M | $10M | $11M | $11M | |
| Operating Cash Flow | $-57M | $-119M | $-96M | $-88M | $-77M | $-111M | $-133M | $-84M | $-73M | $-100M | $-72M | $-62M | $-67M | $-95M | $-66M | $-71M | |
| CapEx | $1M | $769.0K | $1M | $2M | $875.0K | $766.0K | $967.0K | $419.0K | $158.0K | $141.0K | $234.0K | $369.0K | $-3.0K | $399.0K | $113.0K | $38.0K | |
| Investing Cash Flow | $40M | $141M | $90M | $96M | $79M | $113M | $-49M | $251M | $37M | $125M | $96M | $39M | $47M | $58M | $83M | $104M | |
| Stock Repurchased | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Financing Cash Flow | $3M | $2M | $3M | $4M | $65.0K | $2M | $5M | $3M | $1M | $6M | $847.0K | $2M | $237.0K | $2M | $22.0K | $1M | |
| Net Change in Cash | $-14M | $24M | $-4M | $12M | $2M | $3M | $-177M | $169M | $-34M | $31M | $24M | $-20M | $-19M | $-35M | $17M | $34M | |
| Taxes Paid | $70.0K | $4.0K | $-940.0K | $65.0K | $1M | $188.0K | $44M | $-34.0K | $-78.0K | $-525.0K | $-17.0K | $785.0K | $801.0K | $0 | · | $98.0K | |
| Free Cash Flow | · | $-120M | · | · | · | $-112M | · | · | · | $-100M | · | · | · | $-96M | · | · |
लाभप्रदता
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -247.1% | -530.3% | · | -907.4% | -1020.1% | -1222.0% | · | -1146.9% | -1228.3% | -1124.3% | · | -1363.7% | -1396.0% | -1615.5% | · | -2590.7% | |
| Net Margin | -225.1% | -477.7% | · | -803.0% | -899.4% | -1023.2% | · | 10574.7% | -1115.7% | -995.8% | · | -1234.3% | -1248.6% | -1444.4% | · | -2325.0% | |
| Pretax Margin | · | · | · | -803.0% | · | · | · | 11167.3% | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -247.1% | -530.3% | · | -907.4% | -1020.1% | -1222.0% | · | -1146.9% | -1228.3% | -1124.3% | · | -1363.7% | -1396.0% | -1615.5% | · | -2590.7% | |
| ROA | -7.8% | -7.2% | · | -6.5% | -10.0% | -7.4% | · | 67.7% | -10.3% | -8.2% | · | -8.3% | -7.2% | -6.5% | · | -6.0% | |
| ROE | -8.4% | -7.7% | · | -7.1% | -11.0% | -8.1% | · | 75.4% | -11.8% | -9.2% | · | -9.4% | -8.0% | -7.2% | · | -6.7% | |
| ROIC | · | · | · | -9.1% | · | · | · | -6.0% | · | · | · | · | · | · | · | · |
तरलता और शोधन क्षमता
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.2 | 14.2 | · | 13.8 | 14.5 | 18.5 | · | 9.0 | 10.1 | 12.8 | · | 12.1 | 13.7 | 17.5 | · | 14.6 | |
| Quick Ratio | 1.4 | 1.9 | · | 1.2 | 1.1 | 1.5 | · | 2.1 | 1.3 | 2.3 | · | 1.1 | 1.5 | 2.3 | · | 2.3 |
दक्षता
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Inventory Turnover | 0.1 | 0.0 | · | 0.1 | 0.1 | 0.0 | · | 0.0 | 0.1 | 0.0 | · | 0.1 | 0.1 | 0.1 | · | 0.1 |
प्रति शेयर
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $17.21 | $18.69 | · | $22.04 | $23.60 | $25.33 | · | $28.53 | $11.61 | $13.11 | · | $15.87 | $17.30 | $18.66 | · | $19.13 | |
| Revenue / Share | $0.75 | $0.35 | · | $0.22 | $0.21 | $0.15 | · | $0.15 | $0.15 | $0.15 | · | $0.13 | $0.12 | $0.10 | · | $0.06 | |
| Cash Flow / Share | · | $-2.02 | · | · | · | $-1.94 | · | · | · | $-1.77 | · | · | · | $-1.72 | · | · | |
| Cash / Share | $1.67 | $1.91 | · | $1.59 | $1.39 | $1.36 | · | $4.45 | $1.49 | $2.09 | · | $1.15 | $1.52 | $1.88 | · | $2.23 | |
| EPS (TTM) | $-7.02 | $-7.26 | · | $-6.70 | $11.30 | $11.54 | · | $11.37 | $-6.49 | $-6.31 | · | $-3.94 | $-3.79 | $-3.96 | · | $-2.34 |
मूल्यांकन (TTM)
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $98M | $66M | · | $45M | $41M | $37M | · | $33M | $31M | $29M | · | $24M | $20M | $19M | · | $10M | |
| Net Income TTM | $-411M | $-423M | · | $-401M | $650M | $666M | · | $674M | $-365M | $-353M | · | $-220M | $-210M | $-218M | · | $-363M | |
| Market Cap | $2.21B | $2.01B | · | $2.34B | $1.93B | $1.70B | · | $2.53B | $2.45B | $1.66B | · | $1.38B | $1.58B | $1.28B | · | $1.55B | |
| P/E | -5.3 | -4.7 | · | -6.0 | 2.9 | 2.5 | · | 3.9 | -6.6 | -4.6 | · | -6.3 | -7.5 | -5.8 | · | -12.1 | |
| P/S | 22.5 | 30.4 | · | 52.2 | 47.2 | 45.8 | · | 77.1 | 78.3 | 56.4 | · | 57.6 | 78.3 | 67.1 | · | 156.3 | |
| P/B | 2.2 | 1.8 | · | 1.8 | 1.4 | 1.2 | · | 1.6 | 3.7 | 2.2 | · | 1.6 | 1.6 | 1.2 | · | 1.5 | |
| P / Tangible Book | 2.2 | 1.8 | · | 1.8 | 1.4 | 1.2 | · | 1.6 | 3.7 | 2.2 | · | 1.6 | 1.6 | 1.2 | · | 1.5 | |
| P / Cash Flow | · | -16.9 | · | · | · | -15.2 | · | · | · | -16.6 | · | · | · | -13.4 | · | · | |
| Earnings Yield | -18.9% | -21.5% | · | -16.7% | 34.0% | 39.4% | · | 25.6% | -15.0% | -21.6% | · | -15.9% | -13.4% | -17.2% | · | -8.3% |
सबसे हाल की अवधि बाईं ओर · शून्य मान इस प्रकार दिखाए गए हैं ·
वित्तीय विवरण आय विवरण, बैलेंस शीट, नकदी प्रवाह — वार्षिक, पिछले 5 वर्ष
| मेट्रिक | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| राजस्व | $54M | $36M | $27M | $14M | $0 |
| परिचालन मार्जिन % | -873.9% | -1166.5% | -1459.5% | -2732.1% | · |
| शुद्ध आय | $-413M | $674M | $-352M | $-232M | $1.60B |
| तनुकरणित EPS | $-7.12 | $11.64 | $-6.33 | $-4.23 | $26.55 |
| मेट्रिक | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| वर्तमान अनुपात | 11.5 | 11.9 | 12.3 | 13.3 | 17.8 |
| त्वरित अनुपात | 1.1 | 0.9 | 1.3 | 2.2 | 3.4 |
| मेट्रिक | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| फ्री कैश फ्लो | $-377M | $-392M | $-297M | $-314M | $-413M |
संस्थागत मालिक (13F) 262 फाइलर्स · $2.7B कुल · तिथि अनुसार 30 सितमबर 2026
संस्थान जो अपनी तिमाही SEC फॉर्म 13F में इस स्टॉक को होल्ड करने की रिपोर्ट करते हैं। केवल लॉन्ग पोजीशन; एक ही फाइलर अलग-अलग ऑप्शन लेग्स के लिए दो बार दिखाई दे सकता है। बड़े ऑफसेटिंग पुट/कॉल लेग्स आमतौर पर मार्केट-मेकिंग या हेज्ड इन्वेंट्री को दर्शाते हैं, न कि दिशात्मक विश्वास को।
धारक
262
धारित मूल्य
$2.7B
नई स्थितियाँ
39
बाहर निकली पोजीशन
30
संस्थागत गतिविधि — Q2 2026 बनाम पिछली तिमाही
| नई स्थितियाँ | बाहर निकली पोजीशन | बढ़ाया | घटा हुआ | शुद्ध शेयर परिवर्तन |
|---|---|---|---|---|
| 39 (-2 पिछली तिमाही की तुलना में) | 30 (-2 पिछली तिमाही की तुलना में) | 96 (+16 पिछली तिमाही की तुलना में) | 69 (-19 पिछली तिमाही की तुलना में) | +8.4M |
Q1 2026 की तुलना में। SEC फॉर्म 13F फाइलिंग तिमाही के अंत के 45 दिनों के भीतर देय होती है, साथ ही देर से फाइल करने वालों के लिए एक छोटा बफर भी होता है — उस विंडो के भीतर आने वाली तिमाहियों को सबसे हालिया पूरी तरह से रिपोर्ट की गई जोड़ी के पक्ष में छोड़ दिया जाता है।
| संस्था | मूल्य | शेयर | % ट्रैक किए गए 13F का | प्रकार |
|---|---|---|---|---|
| BlackRock, Inc. | $239582050 | 6455997 | 8.88% | शेयर |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | $219594714 | 5917400 | 8.14% | शेयर |
| VANGUARD GROUP INC | $152278288 | 5594353 | 5.64% | शेयर |
| STATE STREET CORP | $131144972 | 3533633 | 4.86% | शेयर |
| Lynx1 Capital Management LP | $126505652 | 3408937 | 4.69% | शेयर |
| D. E. Shaw & Co., Inc. | $115300956 | 3107005 | 4.27% | शेयर |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $107552091 | 2898197 | 3.98% | शेयर |
| ARMISTICE CAPITAL, LLC | $104279100 | 2810000 | 3.86% | कॉल ऑप्शन |
| VANGUARD CAPITAL MANAGEMENT LLC | $99523268 | 2681845 | 3.69% | शेयर |
| ARMISTICE CAPITAL, LLC | $89064000 | 2400000 | 3.30% | शेयर |
| Erste Asset Management GmbH | $81972396 | 2154900 | 3.04% | शेयर |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $78332000 | 2110809 | 2.90% | शेयर |
| GEODE CAPITAL MANAGEMENT, LLC | $58433490 | 1574268 | 2.17% | शेयर |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $51046957 | 1375558 | 1.89% | शेयर |
| ADAR1 Capital Management, LLC | $47799647 | 1288053 | 1.77% | शेयर |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $47502433 | 1280044 | 1.76% | शेयर |
| DIMENSIONAL FUND ADVISORS LP | $46345467 | 1248738 | 1.72% | शेयर |
| GOLDMAN SACHS GROUP INC | $42711087 | 1150932 | 1.58% | शेयर |
| UBS Group AG | $36584189 | 985831 | 1.36% | शेयर |
| MORGAN STANLEY | $35746487 | 963256 | 1.32% | शेयर |
| Nuveen, LLC | $32417811 | 873560 | 1.20% | शेयर |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $30078768 | 810530 | 1.11% | शेयर |
| Foresite Capital Management VI LLC | $29131350 | 785000 | 1.08% | शेयर |
| CITADEL ADVISORS LLC | $27190015 | 732687 | 1.01% | शेयर |
| AQR CAPITAL MANAGEMENT LLC | $25395858 | 684340 | 0.94% | शेयर |
| Parkman Healthcare Partners LLC | $24828297 | 669046 | 0.92% | शेयर |
| SCS Capital Management LLC | $22742864 | 612850 | 0.84% | शेयर |
| Qube Research & Technologies Ltd | $22178346 | 597638 | 0.82% | शेयर |
| NORTHERN TRUST CORP | $20585250 | 554709 | 0.76% | शेयर |
| Defilade Capital Management, L.P. | $20293529 | 546848 | 0.75% | शेयर |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $19969930 | 538128 | 0.74% | शेयर |
| TWO SIGMA INVESTMENTS, LP | $19905062 | 536380 | 0.74% | शेयर |
| Rock Springs Capital Management LP | $19763413 | 532563 | 0.73% | शेयर |
| Schonfeld Strategic Advisors LLC | $19300279 | 520083 | 0.72% | शेयर |
| BANK OF AMERICA CORP /DE/ | $18847034 | 507869 | 0.70% | शेयर |
| Point72 Asset Management, L.P. | $18790426 | 506344 | 0.70% | शेयर |
| JANE STREET GROUP, LLC | $18280312 | 492598 | 0.68% | शेयर |
| Legal & General Group Plc | $16132422 | 434719 | 0.60% | शेयर |
| VANGUARD FIDUCIARY TRUST CO | $14690661 | 395868 | 0.54% | शेयर |
| PANAGORA ASSET MANAGEMENT INC | $13876579 | 373931 | 0.51% | शेयर |
| KENNEDY CAPITAL MANAGEMENT LLC | $13850565 | 373230 | 0.51% | शेयर |
| JPMORGAN CHASE & CO | $13783528 | 359756 | 0.51% | शेयर |
| Connor, Clark & Lunn Investment Management Ltd. | $13342901 | 359550 | 0.49% | शेयर |
| Squarepoint Ops LLC | $11917431 | 321138 | 0.44% | शेयर |
| Ensign Peak Advisors, Inc | $11045049 | 297630 | 0.41% | शेयर |
| BNP PARIBAS FINANCIAL MARKETS | $9996803 | 269383 | 0.37% | शेयर |
| ALGERT GLOBAL LLC | $9203540 | 248007 | 0.34% | शेयर |
| JANE STREET GROUP, LLC | $7974939 | 214900 | 0.30% | पुट ऑप्शन |
| Palo Alto Investors LP | $7926733 | 213601 | 0.29% | शेयर |
| Tetragon Partners GP Ltd | $7629037 | 205579 | 0.28% | शेयर |
कार्यकर्ता और 5%+ मालिक 3 होल्डिंग्स
जिन निवेशकों ने SEC शेड्यूल 13D दाखिल किया है — जारीकर्ता को प्रभावित करने के इरादे से 5% से अधिक लाभकारी स्वामित्व (कार्यकर्ता दांव, बोर्ड अभियान, M&A)। प्रत्येक पंक्ति उस फाइलर की स्थिति की सबसे हालिया ज्ञात स्थिति दिखाती है।
| फाइलर | दाखिल किया | दांव | स्थिति | उद्देश्य | फाइलिंग |
|---|---|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY, CELGENE CORPORATION, CELGENE SWITZERLAND LLC, CELGENE EUROPEAN INVESTMENT COMPANY LLC, CELGENE ALPINE INVESTMENT CO., LLC | 5 अप्रैल 2021 | · | प्रारंभिक फाइलिंग | · | SEC |
| CELGENE SWITZERLAND LLC, CELGENE EUROPEAN INVESTMENT COMPANY LLC, CELGENE ALPINE INVESTMENT CO., LLC, CELGENE CORPORATION ×3 फाइलिंग | 14 नवमबर 2019 | · | प्रारंभिक फाइलिंग | पूंजी संरचना | SEC |
| CELGENE EUROPEAN INVESTMENT COMPANY LLC, CELGENE ALPINE INVESTMENT CO., LLC, CELGENE CORPORATION ×3 फाइलिंग | 17 दिसमबर 2014 | · | प्रारंभिक फाइलिंग | पूंजी संरचना | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
कंपनी के अंदरूनी सूत्र 38 इनसाइडर्स · 18 अधिकारी · 20 निदेशक
| अंदरूनी | भूमिका | अंतिम गतिविधि | शेयरों का स्वामित्व | खरीद 12m | बिक्री 12m | नेट 12m |
|---|---|---|---|---|---|---|
| Brian Goff | Chief Executive Officer | 18 जून 2026 A | 184508 | 0 | 7 | $-1691387 |
| Cecilia Jones | Chief Financial Officer | 18 जून 2026 A | 54998 | 0 | 6 | $-334266 |
| Jonathan Biller | Chief Financial Officer | 1 मार्च 2022 A | 22953 | 0 | 0 | $0 |
| Andrew Hirsch | Chief Financial Officer | 22 अप्रैल 2020 M | 24272 | 0 | 0 | $0 |
| John Duncan Higgons | Chief Operating Officer | 4 जनवरी 2016 M | 120834 | 0 | 0 | $0 |
| Sarah Gheuens | Chief Medical Officer | 4 अगस्त 2026 S | 54645 | 0 | 10 | $-1625034 |
| Krishnan Viswanadhan | Chief Strategy and Operations | 18 जून 2026 A | 10282 | 0 | 2 | $-184967 |
| Tsveta Milanova | Chief Commercial Officer | 18 जून 2026 A | 46829 | 0 | 5 | $-353311 |
| James William Burns | Chief Legal Officer | 18 जून 2026 A | 49306 | 0 | 6 | $-344391 |
| Theodore James Washburn Jr. | Principal Accounting Officer | 3 मार्च 2026 S | 868 | 0 | 4 | $-216633 |
| Richa Poddar | Chief Commercial Officer | 15 अक्टूबर 2022 M | 8508 | 0 | 0 | $0 |
| Bruce Car | Chief Scientific Officer | 1 मार्च 2022 A | 16752 | 0 | 0 | $0 |
| Carman Alenson | Principal Accounting Officer | 21 जून 2021 M | 0 | 0 | 0 | $0 |
| Christopher Bowden | Chief Medical Officer | 18 जून 2021 M | 15487 | 0 | 0 | $0 |
| Darrin Miles | Chief Commercial Officer | 14 मई 2021 S | 7209 | 0 | 0 | $0 |
| Scott Biller | Chief Scientific Officer | 11 जून 2019 M | 33729 | 0 | 0 | $0 |
| Steven L. Hoerter | Chief Commercial Officer | 4 मार्च 2019 M | 10941 | 0 | 0 | $0 |
| Glenn Goddard | Senior Vice President, Finance | 16 फ़रवरी 2016 A | 0 | 0 | 0 | $0 |
| Jay T. Backstrom | निदेशक | 8 जुलाई 2026 M | 1447 | 0 | 0 | $0 |
| Adams Catherine Owen | निदेशक | 18 जून 2026 A | 10865 | 0 | 0 | $0 |
| Rahul D. Ballal | निदेशक | 18 जून 2026 A | 15230 | 0 | 0 | $0 |
| David Scadden | निदेशक | 18 जून 2026 A | 20419 | 0 | 2 | $-16968 |
| Maykin Ho | निदेशक | 18 जून 2026 A | 19848 | 0 | 0 | $0 |
| Cynthia Smith | निदेशक | 18 जून 2026 A | 15230 | 0 | 0 | $0 |
| Jacqualyn A Fouse | निदेशक | 18 जून 2026 A | 154156 | 0 | 0 | $0 |
| Kaye I Foster-Cheek | निदेशक | 18 जून 2026 A | 10284 | 0 | 0 | $0 |
| Jeffrey D Capello | निदेशक | 18 जून 2026 A | 10865 | 0 | 0 | $0 |
| David P Schenkein | निदेशक | 20 जून 2024 A | 126242 | 0 | 0 | $0 |
| Paul J Clancy | निदेशक | 21 जून 2022 A | 6549 | 0 | 0 | $0 |
| John Maraganore | निदेशक | 21 जून 2022 A | 30028 | 0 | 0 | $0 |
| Ian T Clark | निदेशक | 20 मई 2022 M | 6549 | 0 | 0 | $0 |
| Lewis Clayton Cantley Jr. | निदेशक | 7 दिसमबर 2017 S | 79515 | 0 | 0 | $0 |
| Robert Nelsen | निदेशक | 6 मार्च 2017 S | 0 | 0 | 0 | $0 |
| Douglas G. Cole | निदेशक | 10 अगस्त 2016 J | 2778 | 0 | 0 | $0 |
| Marc Tessier-Lavigne | निदेशक | 21 जून 2016 A | 101009 | 0 | 0 | $0 |
| Perry A Karsen | निदेशक | 23 जून 2015 A | · | 0 | 0 | $0 |
| Kevin P Starr | निदेशक | 19 फ़रवरी 2015 J | 184386 | 0 | 0 | $0 |
| Celgene European Investment Co LLC | 10% मालिक | 16 दिसमबर 2014 P | 1231778 | 0 | 0 | $0 |
SEC फॉर्म 3/4/5 फाइलिंग से अंदरूनी सूत्र; नेट = केवल ओपन-मार्केट P/S
ईटीएफ स्वामित्व 43 ETFs द्वारा धारित
वजन केवल प्रत्यक्ष इक्विटी होल्डिंग्स (N-PORT) को दर्शाता है; लीवरेज्ड या डेरिवेटिव-आधारित फंड में अतिरिक्त स्वैप एक्सपोजर हो सकता है जो नहीं दिखाया गया है।
| फंड | भार | इकाइयाँ | तिथि अनुसार | स्रोत |
|---|---|---|---|---|
| BBP · ETFis Series Trust I | 1.40% | 46067 NS | 31 जुलाई 2026 | N-PORT |
| HAPS · Harbor ETF Trust | 0.82% | 46575 NS | 31 जुलाई 2026 | N-PORT |
| QQQS · Invesco Exchange-Traded Fund Trust … | 0.50% | 3546 SH | 2 अक्टूबर 2026 | दैनिक |
| LABU · Direxion Shares ETF Trust | 0.41% | 67945 NS | 31 जुलाई 2026 | N-PORT |
| FYC · First Trust Exchange-Traded AlphaDE… | 0.32% | 139210 NS | 31 जुलाई 2026 | N-PORT |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0.22% | 17481 SH | 2 अक्टूबर 2026 | दैनिक |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.15% | 119054 SH | 2 अक्टूबर 2026 | दैनिक |
| IBB · iShares Trust | 0.14% | 425302 SH | 11 सितमबर 2026 | दैनिक |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.13% | 48730 SH | 19 अगस्त 2026 | दैनिक |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0.13% | 4219 SH | 2 अक्टूबर 2026 | दैनिक |
| PWS · Pacer Funds Trust | 0.12% | 928 NS | 31 जुलाई 2026 | N-PORT |
| FYX · First Trust Exchange-Traded AlphaDE… | 0.10% | 47013 NS | 31 जुलाई 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.07% | 340226 SH | 19 अगस्त 2026 | दैनिक |
| FAD · First Trust Exchange-Traded AlphaDE… | 0.07% | 12610 NS | 31 जुलाई 2026 | N-PORT |
| IWM · iShares Trust | 0.07% | 1511496 SH | 11 सितमबर 2026 | दैनिक |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0.07% | 15124 NS | 31 जुलाई 2026 | N-PORT |
| ESML · iShares Trust | 0.06% | 50007 SH | 11 सितमबर 2026 | दैनिक |
| VBK · VANGUARD INDEX FUNDS | 0.06% | 788655 SH | 19 अगस्त 2026 | दैनिक |
| RSSL · Global X Funds | 0.06% | 28271 NS | 31 जुलाई 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0.04% | 192387 NS | 31 जुलाई 2026 | N-PORT |
| ISCG · iShares Trust | 0.04% | 10228 SH | 11 सितमबर 2026 | दैनिक |
| DXUV · Dimensional ETF Trust | 0.03% | 5807 NS | 31 जुलाई 2026 | N-PORT |
| VB · VANGUARD INDEX FUNDS | 0.03% | 1364364 SH | 19 अगस्त 2026 | दैनिक |
| VHT · VANGUARD WORLD FUND | 0.03% | 167169 SH | 19 अगस्त 2026 | दैनिक |
| FHLC · FIDELITY COVINGTON TRUST | 0.02% | 26897 NS | 31 जुलाई 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.02% | 683802 SH | 19 अगस्त 2026 | दैनिक |
| WSML · iShares Trust | 0.02% | 3364 SH | 11 सितमबर 2026 | दैनिक |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.01% | 3639 SH | 19 अगस्त 2026 | दैनिक |
| DFAC · Dimensional ETF Trust | 0.01% | 148210 NS | 31 जुलाई 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.01% | 9209 NS | 31 जुलाई 2026 | N-PORT |
| IWO · iShares Trust | 0.01% | 31737 SH | 11 सितमबर 2026 | दैनिक |
| TILT · FlexShares Trust | 0.01% | 4553 NS | 31 जुलाई 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0.00% | 17627 NS | 31 जुलाई 2026 | N-PORT |
| IWV · iShares Trust | 0.00% | 16716 SH | 11 सितमबर 2026 | दैनिक |
| ITOT · iShares Trust | 0.00% | 76792 SH | 11 सितमबर 2026 | दैनिक |
| DFUS · Dimensional ETF Trust | 0.00% | 17217 NS | 31 जुलाई 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 1890189 SH | 19 अगस्त 2026 | दैनिक |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0.00% | 46943 SH | 19 अगस्त 2026 | दैनिक |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 4834 SH | 19 अगस्त 2026 | दैनिक |
| ESGV · VANGUARD WORLD FUND | 0.00% | 13097 SH | 19 अगस्त 2026 | दैनिक |
| IWN · iShares Trust | · | 521555 SH | 11 सितमबर 2026 | दैनिक |
| ISCB · iShares Trust | · | 2551 SH | 11 सितमबर 2026 | दैनिक |
| ISCV · iShares Trust | · | 5020 SH | 11 सितमबर 2026 | दैनिक |
AGIO विश्लेषक सर्वसम्मति तेजी और मंदी के विश्लेषक राय, 12-महीने का मूल्य लक्ष्य, अपसाइड
रेटिंग · 16 विश्लेषक
खरीदें
मध्यिका लक्ष्य
$44.50
+39.9%
5 31.2%
मजबूत खरीद
7 43.8%
खरीदें
4 25.0%
होल्ड
0 0.0%
बेचें
0 0.0%
मजबूत बिक्री
12-महीने का मूल्य लक्ष्य
8 विश्लेषक · 2026-09-27माध्य लक्ष्य $46.25 +45.4%
← सभी लक्ष्यों से नीचे
वर्तमान मूल्य $31.80
निम्न$32.00
माध्य$46.25
उच्च$73.00
सहकर्मी तुलना (GICS उप-उद्योग) प्रमुख मेट्रिक्स बनाम सेक्टर के साथी
वित्तीय वर्ष के आधार पर, प्रत्येक कंपनी के पिछले वित्तीय वर्ष के अंत के बंद भाव के अनुसार कीमतें।
| टिकर | मार्केट कैप | P/E | राजस्व YoY | शुद्ध मार्जिन | ROE | सकल मार्जिन |
|---|---|---|---|---|---|---|
| AGIO | $1.59B | -3.8 | 48.0% | -764.0% | -32.2% | · |
| MLYS | $2.96B | -15.8 | · | · | -32.2% | · |
| BCRX | $1.66B | 6.4 | 94.1% | 30.2% | -97.6% | · |
| ZBIO | $1.98B | -4.3 | 100.0% | -3777.4% | -156.8% | · |
| VCEL | $1.82B | 112.5 | 16.4% | 6.0% | 5.0% | 74.4% |
| BHVN | $1.50B | -1.6 | · | · | -310.8% | · |
| VIR | $841M | -1.9 | -7.6% | -638.9% | -51.1% | · |
| PVLA | $1.30B | -28.2 | 65.3% | -1610.6% | -110.1% | · |
| ABSI | $529M | -4.2 | -38.2% | -4113.7% | -63.5% | · |
| SRPT | $2.26B | -3.0 | 15.6% | -32.5% | -57.1% | · |
| GENB | · | · | · | · | · | · |
ताज़ा समाचार इस कंपनी का उल्लेख करने वाली हालिया सुर्खियां
मेरे मेट्रिक्स आपकी व्यक्तिगत वॉचलिस्ट — पूर्ण फंडामेंटल से चयनित पंक्तियाँ
उन मेट्रिक्स को चुनें जो आपके लिए मायने रखते हैं — ऊपर फुल फंडामेंटल्स में किसी भी पंक्ति के बगल में + पर क्लिक करें।
आपका चयन सहेजा गया है और यह सभी टिकर में आपके साथ रहता है।
स्रोत: SEC 10-Q जुल 30, 2026 को फाइल किया गया